153 related articles for article (PubMed ID: 33541601)
1. Adolescents With Attention-Deficit/Hyperactivity Disorder: Adverse Behaviors and Comorbidity.
Sultan RS; Liu SM; Hacker KA; Olfson M
J Adolesc Health; 2021 Feb; 68(2):284-291. PubMed ID: 33541601
[TBL] [Abstract][Full Text] [Related]
2. The effects of temporally secondary co-morbid mental disorders on the associations of DSM-IV ADHD with adverse outcomes in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).
Kessler RC; Adler LA; Berglund P; Green JG; McLaughlin KA; Fayyad J; Russo LJ; Sampson NA; Shahly V; Zaslavsky AM
Psychol Med; 2014 Jun; 44(8):1779-92. PubMed ID: 24103255
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity of disruptive behavioral disorders and attention-deficit hyperactivity disorder--indicator of severity in problematic behavior?
Nordström T; Ebeling H; Hurtig T; Rodriguez A; Savolainen J; Moilanen I; Taanila A
Nord J Psychiatry; 2013 Aug; 67(4):240-8. PubMed ID: 23126481
[TBL] [Abstract][Full Text] [Related]
4. Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment.
Regan T; Tubman J
Subst Use Misuse; 2020; 55(1):119-132. PubMed ID: 31502500
[No Abstract] [Full Text] [Related]
5. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
6. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
Keresztény A; Dallos G; Miklósi M; Róka A; Gádoros J; Balázs J
Psychiatr Hung; 2012; 27(3):165-73. PubMed ID: 22781541
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes.
Upadhyay N; Chen H; Mgbere O; Bhatara VS; Aparasu RR
Subst Use Misuse; 2017 Aug; 52(10):1266-1274. PubMed ID: 28323525
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity of anxiety/affective, conduct/antisocial, attention deficit, and alcohol use disorders with suicidal behaviors in an American Indian community sample of adults and adolescents.
Ehlers CL; Gilder DA; Karriker-Jaffe KJ; Bernert R
J Psychiatr Res; 2023 Nov; 167():63-70. PubMed ID: 37837862
[TBL] [Abstract][Full Text] [Related]
9. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.
Schubiner H; Tzelepis A; Milberger S; Lockhart N; Kruger M; Kelley BJ; Schoener EP
J Clin Psychiatry; 2000 Apr; 61(4):244-51. PubMed ID: 10830144
[TBL] [Abstract][Full Text] [Related]
12. Six-year follow-up study of combined type ADHD from childhood to young adulthood: Predictors of functional impairment and comorbid symptoms.
Cadman T; Findon J; Eklund H; Hayward H; Howley D; Cheung C; Kuntsi J; Glaser K; Murphy D; Asherson P
Eur Psychiatry; 2016 May; 35():47-54. PubMed ID: 27077377
[TBL] [Abstract][Full Text] [Related]
13. The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives.
Biederman J; Faraone SV
Psychiatr Clin North Am; 2004 Jun; 27(2):225-32. PubMed ID: 15063995
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and psychiatric comorbidity of attention-deficit/hyperactivity disorder in an adolescent Finnish population.
Smalley SL; McGough JJ; Moilanen IK; Loo SK; Taanila A; Ebeling H; Hurtig T; Kaakinen M; Humphrey LA; McCracken JT; Varilo T; Yang MH; Nelson SF; Peltonen L; Järvelin MR
J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1575-83. PubMed ID: 18030079
[TBL] [Abstract][Full Text] [Related]
15. Anxiety and disruptive behavior mediate pathways from attention-deficit/hyperactivity disorder to depression.
Roy A; Oldehinkel AJ; Verhulst FC; Ormel J; Hartman CA
J Clin Psychiatry; 2014 Feb; 75(2):e108-13. PubMed ID: 24602257
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.
McGough JJ; Smalley SL; McCracken JT; Yang M; Del'Homme M; Lynn DE; Loo S
Am J Psychiatry; 2005 Sep; 162(9):1621-7. PubMed ID: 16135620
[TBL] [Abstract][Full Text] [Related]
17. A DSM-IV Axis I comorbidity study of males (n = 120) with paraphilias and paraphilia-related disorders.
Kafka MP; Hennen J
Sex Abuse; 2002 Oct; 14(4):349-66. PubMed ID: 12375492
[TBL] [Abstract][Full Text] [Related]
18. Anxiety disorders moderate the association between externalizing problems and substance use disorders: data from the National Comorbidity Survey-Revised.
Hofmann SG; Richey JA; Kashdan TB; McKnight PE
J Anxiety Disord; 2009 May; 23(4):529-34. PubMed ID: 19059752
[TBL] [Abstract][Full Text] [Related]
19. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
[TBL] [Abstract][Full Text] [Related]
20. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication.
Kessler RC; Adler LA; Barkley R; Biederman J; Conners CK; Faraone SV; Greenhill LL; Jaeger S; Secnik K; Spencer T; Ustün TB; Zaslavsky AM
Biol Psychiatry; 2005 Jun; 57(11):1442-51. PubMed ID: 15950019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
